Table 2 Enrichment of disease and drug classes in network communities
Community | Drug ATC Anatomical main group | Disease MeSH class |
|---|---|---|
7 | - | Parasitic diseases |
16 | - | Digestive system diseases |
17 | Antineoplastic and immunomodulating agents | Immune system diseases |
| Â | Musculo-skeletal system | Bacterial infections and mycoses |
18 | Sensory organs | Eye diseases |
| Â | Â | Virus diseases |
25 | - | Stomatognathic diseases |
28 | Genito urinary system and sex hormones | Endocrine system diseases |
| Â | Systemic hormonal preparations excluding sex hormones | Female urogenital diseases and pregnancy complications |
| Â | Â | Male urogenital diseases |
32 | Nervous system | Nervous system diseases |
| Â | Â | Mental disorders |
| Â | Â | Nutritional and metabolic diseases |
37 | Blood and blood forming organs | Hemic and lymphatic diseases |
| Â | Â | Female urogenital diseases and pregnancy complications |
| Â | Â | Male urogenital diseases |
38 | - | Respiratory tract infections |
39 | - | Mental disorders |
41 | - | Nervous system diseases |
51 | - | Endocrine system diseases |
52 | - | Neoplasms |
53 | - | Nutritional and metabolic diseases |
56 | - | Nutritional and metabolic diseases |
| Â | Â | Digestive system diseases |
57 | - | Skin and connective tissue diseases |
59 | - | Endocrine system diseases |
| Â | Â | Musculoskeletal diseases |
60 | - | Stomatognathic diseases |
| Â | Â | Musculoskeletal diseases |
62 | - | Nutritional and metabolic diseases |
| Â | Â | Respiratory tract diseases |
| Â | Â | Bacterial infections and mycoses |
63 | - | Otorhinolaryngologic diseases |
| Â | Â | Eye diseases |
64 | Dermatologicals | Skin and connective tissue diseases |